Denver, CO (PRWEB) March 12, 2015 — CereScan Corp. is proud to announce a groundbreaking partnership agreement with Excel Diagnostics & Nuclear Oncology Center (Excel) in Houston, Texas. This collaborative effort will expand CereScan’s sophisticated brain diagnostics products and Excel’s state of the art neuroimaging capabilities to adults and children who are suffering from “invisible brain issues.” This partnership creates a powerful combination of cutting edge technologies focused on identifying specific brain-related problems such as chronic traumatic brain injury, concussions, Alzheimer’s disease, and attention deficit disorder. The State of Texas and the southwest region of the country now have easy access to the capabilities that these two companies can deliver to medical professionals focused on finding solutions for patients with chronic brain disorders.
CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Since 2009, patients from all over the country and throughout the world have consulted Denver-based CereScan and its leading physicians concerning chronic neurological and psychiatric issues. By partnering with Excel and their extensive experience in nuclear imaging, this Houston center will now offer unmatched functional brain imaging capabilities in the southwest.
Referring and treating medical experts can now rely on CereScan and Excel to offer differentiated diagnoses on a wide array of brain-based disorders including:
- Alzheimer’s Disease
- Parkinson’s Disease
- Anxiety Disorder
- Traumatic Brain Injury
- Bipolar Disorder
- Toxic Brain Injury
- Learning Disorders
“We are excited about the opportunity to team up with Excel Diagnostics in order to serve patients and medical professionals in south Texas and other nearby areas. This business relationship will enable us to further expand our high-quality diagnostic brain imaging capabilities to those patients who are seeking hope and solutions to their mental health problems,” said John Kelley, CEO at CereScan.
With experienced, friendly and professional staffs and facilities designed specifically for comfort and care, CereScan and Excel are dedicated to excellence in patient care. This market expansion provides patients from all over the country with new options in accessing diagnostic technologies that were not in existence a few years ago.
“Collaboration with CereScan will enhance Neuroimaging at Excel Diagnostics and is another testament for our institution to seek cutting edge technology in medical imaging and making it available to our patients and referring physicians!” Structural and functional Neuroimaging is also the back bone of research in this space which will help us to investigate promising treatments for neurological disorders,” said Ebrahim S. Delpassand, M.D. Chairman and Medical Director of Excel Diagnostics and Nuclear Oncology Center.